What is iWorx Systems?
iWorx Systems, Inc. operates as a critical infrastructure provider for the life sciences sector, specializing in high-fidelity physiological data acquisition systems and sophisticated analysis software. By bridging the gap between complex biomedical engineering and accessible educational tools, the company has become a staple in top-tier universities and research institutions globally. Their flagship software, LabScribe, serves as a cornerstone for neurobiology and human physiology research, enabling precise data interpretation that drives academic and clinical discovery. Through its commitment to hardware-software integration, iWorx maintains a dominant footprint in the pedagogical and experimental research markets.
How much funding has iWorx Systems raised?
iWorx Systems has raised a total of $372K across 2 funding rounds:
Debt
$150K
Debt
$222K
Debt (2020): $150K with participation from PPP
Debt (2021): $222K led by PPP
Key Investors in iWorx Systems
PPP
Public-Private Partnership
What's next for iWorx Systems?
With the successful procurement of this latest financing, iWorx Systems is well-positioned to scale its global operations and accelerate the development of next-generation physiological monitoring platforms. The company is expected to leverage this liquidity to deepen its penetration into international research markets and enhance its software-as-a-service capabilities. As the demand for advanced biomedical engineering tools continues to rise, iWorx is likely to focus on strategic product diversification, ensuring that its research-grade solutions remain at the forefront of the life sciences industry. This capital deployment will be instrumental in maintaining their competitive edge against emerging entrants in the digital health and educational technology space.
See full iWorx Systems company page
